Methyl 2-(2-(3'-(Aminomethyl)-[1,1'-biphenyl]-3-carboxamido)phenyl)acetate

ID: ALA4473829

PubChem CID: 90480060

Max Phase: Preclinical

Molecular Formula: C23H22N2O3

Molecular Weight: 374.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)Cc1ccccc1NC(=O)c1cccc(-c2cccc(CN)c2)c1

Standard InChI:  InChI=1S/C23H22N2O3/c1-28-22(26)14-19-7-2-3-11-21(19)25-23(27)20-10-5-9-18(13-20)17-8-4-6-16(12-17)15-24/h2-13H,14-15,24H2,1H3,(H,25,27)

Standard InChI Key:  NJQXPHXXASFTHH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   28.1171   -2.7742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1132   -3.5918    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8208   -3.9992    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5288   -3.5894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5249   -2.7680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8168   -2.3643    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8238   -4.8120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1149   -5.2208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.1155   -6.0372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.8242   -6.4459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5338   -6.0321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.5298   -5.2170    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4081   -6.4463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4086   -7.2635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2305   -2.3557    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9403   -2.7607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.2263   -1.5386    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.6459   -2.3485    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3539   -2.7584    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0591   -2.3469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0553   -1.5288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3405   -1.1241    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6383   -1.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3554   -3.5756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0638   -3.9830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0652   -4.8001    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   33.7708   -3.5731    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   34.4792   -3.9805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
  9 13  1  0
 13 14  1  0
  5 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 25 26  2  0
 25 27  1  0
 27 28  1  0
M  END

Associated Targets(Human)

CFD Tchem Complement factor D (1353 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.44Molecular Weight (Monoisotopic): 374.1630AlogP: 3.78#Rotatable Bonds: 6
Polar Surface Area: 81.42Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.24CX LogP: 3.62CX LogD: 1.80
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -0.89

References

1. Karki RG, Powers J, Mainolfi N, Anderson K, Belanger DB, Liu D, Ji N, Jendza K, Gelin CF, Mac Sweeney A, Solovay C, Delgado O, Crowley M, Liao SM, Argikar UA, Flohr S, La Bonte LR, Lorthiois EL, Vulpetti A, Brown A, Long D, Prentiss M, Gradoux N, de Erkenez A, Cumin F, Adams C, Jaffee B, Mogi M..  (2019)  Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway.,  62  (9): [PMID:30995036] [10.1021/acs.jmedchem.9b00271]

Source